• PhD (Biomedical Science) with postdoctoral research experience in the preclinical development of antibody/polymer therapeutics for cancer treatment.• Track record of scientific accomplishments - Filed 6 patent applications, and published 8 first-authored research articles as well as more than 30 co-author papers in top-tier journals. • Experience in the development and evaluation of antibody-based therapeutics (ADCs, Ab-oligos, and Ab-peptide) and other nanomedicines - Developed antibody/polymer therapeutics for targeting cancer treatment. Characterized the pharmacokinetics, biodistribution, metabolism, targeting effect, and therapeutic efficacy in various preclinical animal models.• Extensive experience and knowledge in pharmaceutics/pharmaceutical chemistry, biomedical science (oncology, biochemistry, molecular and cellular biology), preclinical animal models, and biomedical imaging (PET, SPECT, CT, fluorescence, bioluminescence, FRET).• Leadership and project management: - Successfully managed multiple projects, mentored students, and wrote the reports. Leveraged experts in problem solving.• Work in a multidisciplinary drug-development team for medicinal translation. .